These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 895920)
1. [Acute liver necrosis after treatment with opipramol]. van Vliet AC; Frenkel M; Wilson JH Ned Tijdschr Geneeskd; 1977 Aug; 121(34):1325-7. PubMed ID: 895920 [No Abstract] [Full Text] [Related]
2. Hepatitis caused by antidepressive therapy with maprotiline and opipramol. Braun JS; Geiger R; Wehner H; Schäffer S; Berger M Pharmacopsychiatry; 1998 Jul; 31(4):152-5. PubMed ID: 9754852 [TBL] [Abstract][Full Text] [Related]
3. [Combination of phenylpyrrolidinopentane (Katovit) and oxazepam (Adumbran). A double-blind comparison with opipramol (Insidon) in depressive syndromes]. Gmür M; Angst J Int Pharmacopsychiatry; 1977; 12(2):100-12. PubMed ID: 330439 [No Abstract] [Full Text] [Related]
4. Opipramol in the climacteric syndrome. A double-blind, placebo-controlled trial. van Lith ND; Motké JC Maturitas; 1983 Jun; 5(1):17-23. PubMed ID: 6348485 [TBL] [Abstract][Full Text] [Related]
6. [Ophthalmologic complications during long-term therapy with opipramol]. Kastner W; Lier G Munch Med Wochenschr; 1973 Aug; 115(32):1403-4. PubMed ID: 4741089 [No Abstract] [Full Text] [Related]
7. Opipramol and chlordiazepoxide in the treatment of anxiety in general practice. Murphy JE; Beaumont G; Donald JF Practitioner; 1970 Nov; 205(229):677-83. PubMed ID: 4923895 [No Abstract] [Full Text] [Related]
9. [Opipramol therapy in personal depressions in ambulatory practice, a double-blind study]. Kraft TB Ned Tijdschr Geneeskd; 1969 May; 113(20):889-92. PubMed ID: 4889805 [No Abstract] [Full Text] [Related]
10. [Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression]. Tétreault L; Doucet P; Blanchet A; Bordeleau JM Union Med Can; 1966 May; 95(5):546-53. PubMed ID: 5326793 [No Abstract] [Full Text] [Related]
11. [Insidon in bronchial asthma]. Autran P Mars Med; 1969; 106(11):981-4. PubMed ID: 5407177 [No Abstract] [Full Text] [Related]
12. [Thymoleptic therapy of sleep disorders. Sleep registration following opipramol administration]. Maxion H; Schneider E Med Klin; 1972 Jun; 67(22):778-80. PubMed ID: 4339544 [No Abstract] [Full Text] [Related]
13. [Opipramol (insidon). I. A review on pharmacology, indications and side effects]. Skov F Ugeskr Laeger; 1967 Aug; 129(34):1079-83. PubMed ID: 4877209 [No Abstract] [Full Text] [Related]
15. [Insidon in the treatment of pseudoneurotic reactions and neuroses with prevailing depressive and hypochondriac symptoms]. Alapin B; Sobieraj R Neurol Neurochir Psychiatr Pol; 1966 Feb; 16(2):179-83. PubMed ID: 5913354 [No Abstract] [Full Text] [Related]
16. [Therapeutic experiences with Insidon in neurologic practice]. Tietzen A Med Welt; 1966 Jun; 23():1299-301. PubMed ID: 5984506 [No Abstract] [Full Text] [Related]
17. The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism? Rozanski V; Laux G; Schwarz J Clin Neuropharmacol; 2019; 42(3):77-79. PubMed ID: 30829882 [TBL] [Abstract][Full Text] [Related]
18. Mania, a probable adverse drug reaction of opipramol in a patient with generalized anxiety disorder. Kar SK; Garg K Aust N Z J Psychiatry; 2015 Dec; 49(12):1225-6. PubMed ID: 25900970 [No Abstract] [Full Text] [Related]
19. [A study of the therapeutic effect of an insidon preparation]. Volkova RP Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(2):279-83. PubMed ID: 5786257 [No Abstract] [Full Text] [Related]
20. [Comparative evaluation of antidepressive-anxiolytic substances, with special references to Doxepin (Sinquan), a diphenylmethane derivative]. Terzani S Schweiz Arch Neurol Neurochir Psychiatr; 1972; 110(1):169-82. PubMed ID: 5028388 [No Abstract] [Full Text] [Related] [Next] [New Search]